InspireMD Inc
NASDAQ:NSPR
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
1.85
3.39
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one NSPR stock under the Base Case scenario is 2.62 USD. Compared to the current market price of 2.65 USD, InspireMD Inc is Overvalued by 1%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
InspireMD Inc
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for NSPR cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Economic Moat
InspireMD Inc
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
InspireMD Inc
Balance Sheet Decomposition
InspireMD Inc
Current Assets | 46.4m |
Cash & Short-Term Investments | 40.4m |
Receivables | 2.3m |
Other Current Assets | 3.7m |
Non-Current Assets | 4.1m |
PP&E | 3.1m |
Other Non-Current Assets | 996k |
Current Liabilities | 7.3m |
Accounts Payable | 1.3m |
Accrued Liabilities | 5.8m |
Other Current Liabilities | 186k |
Non-Current Liabilities | 1.9m |
Other Non-Current Liabilities | 1.9m |
Earnings Waterfall
InspireMD Inc
Revenue
|
6.8m
USD
|
Cost of Revenue
|
-5.3m
USD
|
Gross Profit
|
1.5m
USD
|
Operating Expenses
|
-31.5m
USD
|
Operating Income
|
-29.9m
USD
|
Other Expenses
|
1.7m
USD
|
Net Income
|
-28.2m
USD
|
Free Cash Flow Analysis
InspireMD Inc
USD | |
Free Cash Flow | USD |
NSPR Profitability Score
Profitability Due Diligence
InspireMD Inc's profitability score is 25/100. The higher the profitability score, the more profitable the company is.
Score
InspireMD Inc's profitability score is 25/100. The higher the profitability score, the more profitable the company is.
NSPR Solvency Score
Solvency Due Diligence
InspireMD Inc's solvency score is 61/100. The higher the solvency score, the more solvent the company is.
Score
InspireMD Inc's solvency score is 61/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
NSPR Price Targets Summary
InspireMD Inc
According to Wall Street analysts, the average 1-year price target for NSPR is 4.59 USD with a low forecast of 4.55 USD and a high forecast of 4.73 USD.
Dividends
Current shareholder yield for NSPR is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Ownership
NSPR Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Profile
Country
Industry
Market Cap
Dividend Yield
Description
InspireMD, Inc. operates as a medical device company, which engages in the development and commercialization of the stent platform technology for the treatment of complex vascular and coronary disease. The firm is focusing on the development and commercialization of its MicroNet stent platform technology for the treatment of vascular and coronary disease. Its MicroNet, a micron mesh sleeve, is wrapped over a stent to provide embolic protection in stenting procedures. Its CGuard carotid embolic prevention system (CGuard EPS) combines its MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. Its MGuard Prime Embolic Protection System (MGuard Prime EPS) is marketed for use in patients with acute coronary syndromes, notably acute myocardial infarction (heart attack) and saphenous vein graft coronary interventions (bypass surgery). The company markets and sells MGuard Prime EPS, a bare-metal cobalt-chromium based stent, for the treatment of coronary disease in the European Union. The company is also developing a neurovascular flow diverter (NGuard), which is an endovascular device.
Contact
IPO
Employees
Officers
The intrinsic value of one NSPR stock under the Base Case scenario is 2.62 USD.
Compared to the current market price of 2.65 USD, InspireMD Inc is Overvalued by 1%.